• |
  • |
  • |
  • |
Donate

Product

Real-world performance of an eye-tracking-based diagnostic aid for autism spectrum disorder.

Center:
Fiscal Year:
2026
Contact Information:
Product Description:
To evaluate the real-world performance, clinical feasibility, and predictive validity of an FDA-cleared, eye-tracking-based diagnostic device for autism spectrum disorder (ASD). Retrospective data were gathered from five clinical sites between August 2023 and November 2025. Primary outcomes included device success rates and expert clinician diagnoses.
Keyword(s):
autism/ADC, Medical technology and advancement, Developmental/behavioral health
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals submitted
Target Audience:
Professionals, Policymakers
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A